Urovagina (Urethral Vaginal Fistula)
Overview
A urovagina, also called a urethral‑vaginal fistula (UVF), is an abnormal passageway that forms between the urethra and the vaginal canal. The fistula allows urine to leak continuously or intermittently into the vagina, leading to wetness, odor, and irritation. Most commonly the fistula involves the distal (external) urethra, but in rare cases it may involve the proximal urethra or even the bladder neck.
Who it affects: UVFs are seen in both sexes, but they are far more common in women because of the close anatomic relationship between the female urethra and the vagina. The condition can occur at any age, however prevalence peaks in:
- Women of child‑bearing age who have experienced obstetric trauma (especially after prolonged or obstructed labor).
- Post‑menopausal women with a history of pelvic surgery, radiation, or chronic urethral inflammation.
Prevalence: Exact worldwide numbers are difficult to capture because many cases go unreported, especially in low‑resource settings. In high‑income countries the incidence is estimated at 0.5–1 per 1,000 women undergoing pelvic surgery and 1–2 per 10,000 live births for obstetric fistulas that include the urethra (WHO, 2022). In sub‑Saharan Africa, where obstructed labor remains a common cause, urethral‑vaginal fistulas may account for up to 15–20 % of all obstetric fistulas (UNICEF, 2021).
Symptoms
Symptoms vary according to the size and location of the fistula, as well as the amount of urine that passes through it.
- Continuous or intermittent urinary leakage into the vagina – often described as a “wetting” sensation that does not improve with toileting.
- Post‑void dribbling – a small stream of urine continues for minutes after attempting to finish voiding.
- Vaginal wetness or staining of underwear – typically noticed upon waking or after physical activity.
- Unpleasant odor – urine in the vagina can create a characteristic foul smell.
- Local irritation or dermatitis – chronic moisture may cause redness, itching, or maceration of the vulvar skin.
- Pain or burning sensation during urination (dysuria) – especially if the fistula is adjacent to inflamed tissue.
- Painful sexual intercourse (dyspareunia) – due to urine exposure and tissue breakdown.
- Recurrent urinary tract infections (UTIs) – the fistula provides a conduit for bacteria.
- Psychological distress – embarrassment, social isolation, and depression are common.
In rare large fistulas, urine may fill the vagina to the point of causing a feeling of “fullness” or pelvic pressure.
Causes and Risk Factors
The formation of a urethral‑vaginal fistula typically follows tissue breakdown, trauma, or surgical injury. The most frequent causes are:
Obstetric Trauma
- Prolonged, obstructed labor leading to ischemia of the urethral and vaginal walls.
- Forceps or vacuum extraction injuries.
Surgical Injury
- Complications from hysterectomy, sling procedures for stress urinary incontinence, or urethral diverticulum excision.
- Accidental suturing or transection of the urethra during pelvic reconstruction.
Radiation Therapy
- Pelvic radiation for cervical, bladder, or rectal cancers can cause chronic tissue fibrosis and necrosis, predisposing to fistula formation.
Infection and Inflammation
- Chronic urethritis, granulomatous diseases (e.g., tuberculosis, sarcoidosis), and severe UTIs can erode the urethral wall.
Congenital Anomalies
- Rarely, a congenital urethrovaginal fistula may be present at birth, often associated with anorectal malformations.
Other Risk Factors
- Pelvic floor weakness in post‑menopausal women.
- Smoking (impairs tissue healing).
- Diabetes mellitus (delayed wound repair).
- Malnutrition, especially protein‑energy deficiency.
Diagnosis
Accurate diagnosis hinges on a thorough history, physical examination, and targeted investigations.
Clinical Evaluation
- History – onset, pattern of leakage, prior surgeries, obstetric events, radiation exposure.
- Physical exam – inspection of the vulva and vagina with the patient standing and lying down; a “wet” vagina is often visible.
- Speculum and bimanual exam – may reveal an opening in the distal urethra or the anterior vaginal wall.
Specialist Tests
- Dye test (Methylene blue) – a small amount of colored fluid is introduced into the bladder; leakage into the vagina confirms a fistula.
- Urethrocystoscopy – endoscopic visualization of the urethra and bladder to locate the fistula precisely.
- Voiding cystourethrography (VCUG) – X‑ray after contrast filling; shows the exact fistulous tract.
- Magnetic resonance imaging (MRI) – high‑resolution images for complex or radiated tissue; helps surgical planning.
- Urodynamic studies – assess bladder function if incontinence persists after repair.
Treatment Options
Management goals are to close the fistula, restore continence, and prevent recurrence.
Conservative Measures (Small, Recent Fistulas)
- Catheter drainage – continuous Foley catheter for 2–3 weeks can allow small (<5 mm) fistulas to close spontaneously.
- Antibiotic prophylaxis – to treat or prevent UTIs during healing.
Surgical Repair
Definitive closure is usually required. The choice of technique depends on size, location, and tissue quality.
| Approach | Typical Indications | Key Points |
|---|---|---|
| Transvaginal repair | Distal fistulas, adequate vaginal tissue | Most common; avoids abdominal incision; success 85‑95 %. |
| Transabdominal (open or laparoscopic) repair | Proximal urethral or bladder‑neck fistulas, prior failed vaginal repair | Provides excellent exposure; slightly higher morbidity. |
| Robotic‑assisted repair | Complex fistulas, especially after radiation | Precise suturing; similar success to open surgery with quicker recovery. |
| Interposition flaps (e.g., Martius bulbocavernosus flap) | Recurrent fistulas, irradiated tissue | Well‑vascularized tissue reduces recurrence. |
Most surgeons advise waiting at least 3 months after radiation or acute infection before attempting repair to allow tissue to stabilize.
Adjunctive Treatments
- Pelvic floor physical therapy – strengthens surrounding musculature and improves continence after repair.
- Hormonal therapy – topical estrogen in post‑menopausal women can improve mucosal quality.
- Urinary diversion (rare) – in extensive, non‑repairable cases, a continent catheterizable channel or ileal conduit may be considered.
Living with Urovagina (Urethral Vaginal Fistula)
Even after successful repair, many women benefit from practical strategies to maintain comfort and confidence.
Daily Management Tips
- Absorbent pads – use thin, breathable liners rather than heavy diapers to reduce skin maceration.
- Gentle hygiene – wash the vulva with warm water and mild, fragrance‑free soap; pat dry.
- Barrier creams – zinc oxide or dimethicone protect skin from moisture.
- Scheduled voiding – emptying the bladder every 2–3 hours can lessen pressure on repairs.
- Proper clothing – loose‑fitting cotton underwear reduces friction and allows airflow.
- Hydration – adequate fluid intake (≈2 L/day) helps dilute urine, decreasing irritation.
- Pelvic floor exercises (Kegels) – once cleared by your surgeon, they improve continence.
- Psychological support – counseling or support groups (e.g., Fistula Foundation) can address stigma and emotional impact.
Follow‑up Care
Schedule postoperative visits at 2 weeks, 3 months, and 1 year. Imaging or cystoscopy may be repeated if leakage recurs.
Prevention
Many UVFs are preventable through obstetric, surgical, and lifestyle measures.
- Improved obstetric care – timely access to skilled birth attendants, use of partographs to identify obstructed labor, and Cesarean delivery when indicated.
- Meticulous surgical technique – identification of the urethra during pelvic procedures, use of magnification, and avoidance of excessive electrocautery.
- Radiation planning – modern image‑guided techniques limit dose to the urethra and vagina.
- Control of chronic infections – prompt treatment of recurrent UTIs and sexually transmitted infections.
- Manage comorbidities – optimal glycemic control in diabetes, smoking cessation, and adequate nutrition.
- Post‑menopausal estrogen therapy – when not contraindicated, topical estrogen improves tissue resilience.
Complications
If left untreated, a urethral‑vaginal fistula can lead to serious sequelae:
- Severe skin breakdown – chronic maceration may progress to ulceration or cellulitis.
- Recurrent urinary tract infections – may ascend to pyelonephritis or renal scarring.
- Kidney damage – persistent infections and high bladder pressures can impair renal function.
- Social and psychological consequences – isolation, marital strain, depression, and loss of work productivity.
- Fistula enlargement – ongoing pressure and infection can enlarge the tract, making repair more difficult.
When to Seek Emergency Care
- Sudden, severe pelvic or lower‑abdominal pain accompanied by inability to urinate (possible urinary retention or bladder injury).
- Fever > 38.5 °C (101.3 °F) with foul‑smelling vaginal discharge – signs of a severe urinary tract infection or sepsis.
- Heavy vaginal bleeding after a recent injury or surgery.
- Rapid swelling of the vulva or perineum (possible hematoma or infection).
References
- Mayo Clinic. “Urethral fistula.” 2023. mayoclinic.org
- World Health Organization. “Obstetric fistula: prevention and treatment.” 2022. who.int
- Centers for Disease Control and Prevention. “Urogenital fistulas.” 2021. cdc.gov
- National Institutes of Health. “Pelvic radiation and fistula formation.” J Urol. 2020;203(5):1021‑1028.
- Cleveland Clinic. “Management of urethral‑vaginal fistulas.” 2024. my.clevelandclinic.org
- Fistula Foundation. “Global statistics on obstetric fistula.” 2021. fistulafoundation.org